Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome

Genetics in Medicine

Volumn 12, Issue 5, 2010, Pages 298-303

  Susman, Marleen R ^a   Amor, David J ^a   Muggli, Evelyne ^a   Jaques, Alice M ^a   Halliday, Jane ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Chromosome aberrations; Down syndrome; Karyotyping; Noninvasive; Prenatal diagnosis

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CYTOGENETICS; DOWN SYNDROME; GENETIC SCREENING; HUMAN; INTERMETHOD COMPARISON; KARYOTYPING; MOSAICISM; NON INVASIVE PROCEDURE; POLYPLOIDY; POPULATION GENETICS; PREDICTION; PRENATAL DIAGNOSIS; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18;

AUSTRALIA; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; KARYOTYPING; MASS SCREENING; POPULATION GROUPS; PRENATAL DIAGNOSIS; SEX CHROMOSOME ABERRATIONS; SYNDROME; TRISOMY; VICTORIA;

EID: 77952543729     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181d5d022     Document Type: Article

References (33)

1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.
2. Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000;46:1832-1834.
3. Benachi A, Costa JM. Non-invasive prenatal diagnosis of fetal aneuploidies. Lancet 2007;369:440-442.
4. Chim SS, Jin S, Lee TY, et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 2008;54:500-511.
5. Dhallan R, Guo X, Emche S, et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 2007;369:474-481.
6. Hulten MA, Old RW. Non-invasive prenatal diagnosis of Down's syndrome. Lancet 2007;369:1997; author reply 1998-1999.
7. Lo YM, Lun FM, Chan KC, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007;104: 13116-13121.
8. Lo YM, Tsui NB, Chiu RW, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007;13:218-223.
9. Lo YMD. Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. BJOG 2009;116:152-157.
10. Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008;105:20458-20463.
11. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008;105:16266-16271.
12. Benn PA, Chapman AR. Practical and ethical considerations of noninvasive prenatal diagnosis. JAMA 2009;301:2154-2156
13. Report on Prenatal Diagnostic Testing in Victoria 2007. Available at: http://www.health.vic.gov.au/-data/assets/pdf-file/0016/314206/report- diagnostictest2007.pdf. Accessed October 30, 2009
14. Report on Prenatal Diagnostic Testing in Victoria 2006. Available at: http://www.health.vic.gov.au/--data/assets/pdf-file/0015/314205/report- diagnostictest2006.pdf. Accessed October 30, 2009.
15. Hahn S, Jackson LG, Kolla V, Mahyuddin AP, Choolani M. Noninvasive prenatal diagnosis of fetal aneuploidies and Mendelian disorders: new innovative strategies. Expert Rev Mol Diagn 2009;9:613-621.
16. Lo TK. Screening options for Down syndrome: how women choose in real clinical setting. Prenat Diagn 2009;29:852-856.
17. Cell-free fetal nucleic acids for non-invasive prenatal diagnosis, Report of the UK expert working group, PHG Foundation. Available at: http://www. phgfoundation.org/download/ffdan/ffDNA-report.pdf. Accessed October 28, 2009.
18. Jaques AM, Halliday JL, Francis I, et al. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18. BJOG 2007;114:812-818.
19. Jaques AM, Collins VR, Haynes K, et al. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects. J Med Screen 2006;13:8-13.
20. Caughey AB, Washington AE, Kuppermann M. Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women. Am J Obstet Gynecol 2008;198:333 e331-e338.
21. Tabor A, Vestergaard CH, Lidegaard O. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009;34:19-24.
22. Ratcliffe S. Long-term outcome in children of sex chromosome abnormalities. Arch Dis Child 1999;80:192-195.
23. Baena N, De Vigan C, Cariati E, et al.; EUROSCAN Working Group. Prenatal detection of rare chromosomal autosomal abnormalities in Europe. Am J Med Genet A 2003;118A:319-327.
24. Franssen MT, Korevaar JC, van der Veen F, Leschot NJ, Bossuyt PM, Goddijn M. Reproductive outcome after chromosome analysis in couples with two or more miscarriages: index [corrected]-control study. BMJ 2006; 332:759-763.
25. Holmgren C, Lacoursiere DY. The use of prenatal ultrasound for the detection of fetal aneuploidy. Clin Obstet Gynecol 2008;51:48-61.
26. Gaudry P, Lebbar A, Choiset A, et al. Is rapid aneuploidy screening used alone acceptable in prenatal diagnosis? an evaluation of the possible role of ultrasound examination. Fetal Diagn Ther 2009;25:285-290.
27. Boormans EM, Birnie E, Bilardo CM, et al. Karyotyping or rapid aneuploidy detection in prenatal diagnosis? The different views of users and providers of prenatal care. BJOG 2009;116:1396-1399.
28. Chan YM, Sahota DS, Leung TY, Choy KW, Chan OK, Lau TK. Chinese women's preferences for prenatal diagnostic procedure and their willingness to trade between procedures. Prenat Diagn 2009;29:870-874.
29. Grimshaw G, Szczepura A, Hulten M, et al. Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess 2003;7:1-146.
30. Ryan M, Diack J, Watson V, Smith N. Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women. Prenat Diagn 2005;25:1206-1211.
31. Kooij L, Tymstra T, Berg P. The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenat Diagn 2009;29:164-168.
32. van Zwieten MC, Willems DL, Litjens LL, Schuring-Blom HG, Leschot N. How unexpected are unexpected findings in prenatal cytogenetic diagnosis? A literature review. Eur J Obstet Gynecol Reprod Biol 2005;120:15-21.
33. Skotko BG. With new prenatal testing, will babies with Down syndrome slowly disappear? Arch Dis Child 2009;94:823-826.